VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Prolynx

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 77 out of 100

Advancing Ultra-Long-Acting Medicines for Obesity and Related Metabolic Conditions

  • Biotech & therapeutics
Business model
B2B
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

Prolynx is developing a next-generation portfolio of extended-duration therapeutics designed for once-monthly and once-quarterly dosing.

Products

Web
PLX-821
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy